In brief
- The EU and the UK are increasingly viewing medical technologies and biotechnology as integral components of their security and defense strategies, both military and civilian, bringing life sciences regulation into direct contact with defense and aerospace frameworks.
- For most products, the standard EU and UK life sciences framework
Register for free to keep reading
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day